Lisa Sackuvich, R.N., B.S.N., CRNI
Owner & President
Lisa Sackuvich founded ARJ Infusion Services in 2000 with the idea that children and adults deserve a higher level of infusion care. Her belief is simple: Every patient deserves high-touch, personalized care for treatment of their rare and chronic conditions.
This approach has enabled Lisa to grow the home-based infusion and specialty pharmacy company into a flourishing national organization—without losing focus of her original vision to provide quality, compassionate infusion care. Under Lisa’s leadership, ARJ achieved 97 percent patient satisfaction in 2019 and maintained URAC accreditation.
While ARJ’s headquarters remain in the Kansas City metropolitan area, the organization has successfully expanded operations to include eight dispensing pharmacies and nursing facilities across the Midwest. In 2017, the company launched five new ARJ Infusion Suite locations that offer on-site clinical care to complement its in-home care model.
Most recently ARJ was named among the “Top Largest Private Companies” by Kansas City Business Journal. In 2016, Lisa was recognized as a “Woman Who Means Business” in Kansas City Business Journal’s annual overview of top area business leaders. She has also been honored for her entrepreneurial leadership in such publications as Enterprising Women and Thinking Bigger Business Media.
Lisa is passionate about advocating for patients and the community through numerous philanthropic contributions. Since launching ARJ, she has donated more than $6 million to local and national nonprofits. And through ARJ’s Patient Engagement Department, the company has secured over $7 million in financial assistance and lifestyle resources for patients and families in 2019.
Currently Lisa sits on the board of trustees at Avila University in Kansas City, as well as the board of directors for Myasthenia Gravis Association, where she has also served as president. She has been a member of Infusion Nurses Society since 1990, and is active in Hemophilia Federation of America, Immunoglobulin National Society, Midwest Hemophilia Association, National Hemophilia Foundation, and World Federation of Hemophilia.
